Gastric Cancer and Gastroesophageal Junction Adenocarcinoma
Clinical research activity is centered on resectable diffuse type gastric adenocarcinoma and gastroesophageal junction Type II/III adenocarcinoma, with attention to patients undergoing curative-intent treatment.
- Diffuse type gastric cancer
- Gastroesophageal junction tumors
- Resectable adenocarcinoma
The sponsor’s research interests in this area reflect a focus on disease control and outcomes relevant to surgical oncology and upper gastrointestinal malignancies.
Perioperative Oncology
Trial activity is aligned with perioperative treatment strategies for upper gastrointestinal cancer, including approaches intended to support patients before and after definitive surgery.
- Curative-intent treatment
- Surgical oncology
- Perioperative management
This area connects oncologic treatment planning with the management of localized disease in a hospital-based research setting.
Recurrence and Disease-Free Survival
Research activity includes outcomes related to progression-free survival and disease-free survival, emphasizing measures of recurrence control in patients with resectable disease.
- Progression-free survival
- Disease-free survival
- Recurrence prevention
These endpoints indicate an interest in long-term oncologic outcomes for patients treated for upper gastrointestinal malignancies.
Regional Clinical Collaboration
The sponsor operates within a multi-site research network in Frankfurt and contributes to collaborative clinical work across numerous participating sites in Germany.
- Hospital-based research
- Collaborative oncology network
- Upper gastrointestinal cancer care
Its clinical research profile is focused on institutional participation in oncology studies for patients with localized gastric and gastroesophageal disease.
